Douglas Holtzman

Insider Reports History

Entity
Individual
Location
1616 Eastlake Avenue E., Suite 208, Seattle, WA
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas Holtzman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Icosavax, Inc. Chief Scientific Officer Common Stock 290K $4.55M $15.67 Jul 3, 2023 Direct
Icosavax, Inc. Chief Scientific Officer Common Stock 2.79K $43.8K $15.67 Jul 3, 2023 By Stanley Holtzman(
Icosavax, Inc. Chief Scientific Officer Stock Option (Right to Buy) 28.6K Jul 3, 2023 Direct

Insider Reports Filed by Douglas Holtzman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ICVX Icosavax, Inc. Jul 3, 2023 4 -$128K 4 Jul 3, 2023 Chief Scientific Officer
ICVX Icosavax, Inc. Apr 3, 2023 4 -$103K 4 Apr 5, 2023 Chief Scientific Officer
ICVX Icosavax, Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Scientific Officer
ICVX Icosavax, Inc. Feb 13, 2023 2 -$50.3K 4 Feb 15, 2023 Chief Scientific Officer
ICVX Icosavax, Inc. Dec 15, 2022 1 -$219K 4 Dec 16, 2022 Chief Scientific Officer
ICVX Icosavax, Inc. Nov 10, 2022 1 $0 4 Nov 14, 2022 Chief Scientific Officer
ICVX Icosavax, Inc. Jul 29, 2022 4 -$69.2K 4 Aug 2, 2022 Chief Scientific Officer
ICVX Icosavax, Inc. May 31, 2022 1 $9.62K 5 Feb 14, 2023 Chief Scientific Officer
ICVX Icosavax, Inc. Feb 10, 2022 3 $0 4 Feb 14, 2022 Chief Scientific Officer
ICVX Icosavax, Inc. Jul 30, 2021 4 $623K 4 Aug 2, 2021 Chief Scientific Officer
ICVX Icosavax, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Chief Scientific Officer